Avidity Biosciences, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
RNA Company Description
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.
RNA Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view RNA Smart Score
Score Breakdown
RNA Company Description
Show More
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of RNA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RNA's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on RNA's company Twitter account
WallStreetBets
Number of mentions of RNA in WallStreetBets Daily Discussion
RNA News
Recent insights relating to RNA
CNBC Recommendations
Recent picks made for RNA stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in RNA
Corporate Flights
Flights by private jets registered to RNA
Our Analysis